Information Journal Paper
APA:
Copy. (2020). Negative impact of hyperglycaemia on tocilizumab therapy in COVID-19 patients. DIABETES AND METABOLISM, 46(5), 403-405. SID. https://sid.ir/paper/693754/en
Vancouver:
Copy. Negative impact of hyperglycaemia on tocilizumab therapy in COVID-19 patients. DIABETES AND METABOLISM[Internet]. 2020;46(5):403-405. Available from: https://sid.ir/paper/693754/en
IEEE:
Copy, “Negative impact of hyperglycaemia on tocilizumab therapy in COVID-19 patients,” DIABETES AND METABOLISM, vol. 46, no. 5, pp. 403–405, 2020, [Online]. Available: https://sid.ir/paper/693754/en